Browse study websites

Discover. Prevent. Cure.

Menu Fundraise Donate

    Recommended pages

      Do you mean

        1-10 of 585 results for '9'

        Refine search

        Research

        Techniques and Processes Involved in Nanoencapsulation of Omega-3, -6, and -9 Fatty Acids

        Omega fatty acids are essential for young children’s growth and development. They also have essential functions in cell receptors of membranes and regulation of hormones synthesis. Essential fatty acids such as omega-3 and -6 can only be obtained through food mainly fish and other seafood and to a lesser extent through nuts, seeds, and plant oils. ...

        Research

        Investigating the Implications of CFTR Exon Skipping Using a Cftr Exon 9 Deleted Mouse Model

        Severity and disease progression in people with Cystic Fibrosis is typically dependent on their genotype. One potential therapeutic strategy for people with specific mutations is exon skipping with antisense oligonucleotides. CFTR exon 9 is an in-frame exon and hence the exclusion of this exon would excise only 31 amino acids but not alter the reading frame of the remaining mRNA. ...

        Research

        Association of an allele on chromosome 9 and abdominal aortic aneurysm

        Abdominal aortic aneurysm (AAA) has been recognized as a multi-factorial disease with both genetic and environmental risk factors. ...

        Research

        Student achievement against national minimum standards for reading and numeracy in Years 3, 5, 7 and 9

        Emma Adams EA BExSc, MPH Acting Research Officer -Playce, Research Assistant & PhD student Emma.Adams@telethonkids.org.au Research Assistant, PhD ...

        Research

        Patterns of participation in year 9 academic testing and factors predicting absence on the day of test

        Policies aiming to improve educational outcomes are typically based on academic testing data. However, such data only reflects those who complete the test. ...

        Research

        Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1–9 years: two phase 2 randomised, controlled, observer-blinded studies

        The meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) is licensed for use in children aged 10 years or older for protection against invasive serogroup B meningococcal disease. Because young children are at increased risk of invasive meningococcal disease, MenB-FHbp clinical data in this population are needed. ...

        Research

        History of the exploration of human growth

        History of the exploration of human growth ...

        Research

        Type 2 Diabetes in Indigenous Australian children

        Authors: Maple-Brown LJ, Sinha AK, Davis EA. Authors notes: J Paediatr Child Health. 2010 Sep;46(9):487-90. doi: 10.1111/j.1440-1754.2010.01844.x. ...

        Research

        A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIV

        To evaluate the safety and immunogenicity of V114 [15-valent pneumococcal conjugate vaccine (PCV) containing serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9 V, 14, 18C, 19A, 19F, 22F, 23F, 33F], followed by 23-valent pneumococcal polysaccharide vaccine (PPSV23) 8 weeks later, in children with HIV. ...

        News & Events

        Recruits needed for new tech study

        Meet Sophie - she's Australia's first participant in the multi-site Advanced Hybrid Closed Loop study. ...

        Page 1 of 59